Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 9 Similar Profiles
Tuberculosis
Medicine & Life Sciences
Meningeal Tuberculosis
Medicine & Life Sciences
HIV
Medicine & Life Sciences
Infection
Medicine & Life Sciences
Latent Tuberculosis
Medicine & Life Sciences
Isoniazid
Medicine & Life Sciences
Rifampin
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2016 2019
- 1 Finished
Rifampicin Malabsorption In Hiv+ Patients: Mechanisms And Recovery After Haart
National Institutes of Health (NIH)
3/1/16 → 1/31/19
Project: Research project
Rifampin
HIV
Tuberculosis
Botswana
Research Personnel
Research Output 2008 2019
Adipose tissue regulates pulmonary pathology during TB infection
Ayyappan, J. P., Ganapathi, U., Lizardo, K., Vinnard, C., Subbian, S., Perlin, D. & Nagajyothi, J., Mar 1 2019, In : mBio. 10, 2, e02771-18.Research output: Contribution to journal › Article
Open Access
Mycobacterium tuberculosis
Adipose Tissue
Tuberculosis
Pathology
Lung
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis
Mezochow, A., Thakur, K. T., Zentner, I., Subbian, S., Kagan, L. & Vinnard, C., Jul 1 2019, In : International Journal of Infectious Diseases. 84, p. 15-21 7 p.Research output: Contribution to journal › Article
Open Access
Meningeal Tuberculosis
Rifampin
Meningitis
Cerebrospinal Fluid
Tuberculosis
Dual β-lactam combinations highly active against mycobacterium abscessus complex in vitro
Pandey, R., Chen, L., Manca, C., Jenkins, S., Glaser, L., Vinnard, C., Stone, G., Lee, J., Mathema, B., Nuermberger, E. L., Bonomo, R. A. & Kreiswirth, B., Jan 1 2019, In : mBio. 10, 1, e02895-18.Research output: Contribution to journal › Article
Open Access
Lactams
Ceftazidime
Mycobacterium
Imipenem
Anti-Bacterial Agents
Assessing response to therapy for nontuberculous mycobacterial lung disease: Quo vadis?
Vinnard, C., Mezochow, A., Oakland, H., Klingsberg, R., Hansen-Flaschen, J. & Hamilton, K., Nov 20 2018, In : Frontiers in Microbiology. 9, NOV, 02813.Research output: Contribution to journal › Review article
Lung Diseases
Biomarkers
Therapeutics
Pharmaceutical Preparations
Standard of Care
5
Citations
(Scopus)
Effect of Mycobacterium tuberculosis infection on adipocyte physiology
Ayyappan, J. P., Vinnard, C., Subbian, S. & Nagajyothi, J. F., Feb 1 2018, In : Microbes and Infection. 20, 2, p. 81-88 8 p.Research output: Contribution to journal › Article
Mycobacterium Infections
Mycobacterium tuberculosis
Adipocytes
Adipose Tissue
Lung